Prostate Neoplasms
Showing 1 - 25 of 37
Prostate Cancer, Prostate Tumors Trial run by the CC (ultrasound image-guided ablation device)
Suspended
- Prostate Cancer
- Prostate Neoplasms
- ultrasound image-guided ablation device
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 20, 2023
Novel Therapy Target in Metastatic Prostate Cancer
Not yet recruiting
- Prostate Neoplasms
- Tissue
- (no location specified)
Oct 10, 2022
Prostate Specific Antigens, Prostate Tumors Trial run by the National Cancer Institute (NCI) (TARP peptide vaccine, TARP
Completed
- Prostate Specific Antigens
- Prostate Neoplasms
- T-cell receptor alternate reading frame protein (TARP) peptide vaccine
- T-cell receptor alternate reading frame protein (TARP) dendritic cell vaccine
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Sep 15, 2022
Prostate Tumors, Prostatic Cancer, Prostate Cancer Trial run by the National Cancer Institute (NCI) (18F-DCFPyL, 18F-FDG,
Enrolling by invitation
- Prostate Neoplasms
- +4 more
- 18F-DCFPyL
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Aug 17, 2022
Prostatic Tumors, Prostate Tumors, Prostate Cancer Trial in New York (5-Azacitidine, all trans retinoic acid, Lupron)
Completed
- Prostatic Neoplasms
- +2 more
- 5-Azacitidine
- +2 more
-
New York, New YorkIcahn School of Medicine at Mount Sinai
Aug 1, 2022
Metastatic Castration Resistant Prostate Cancer, Prostate Tumors Trial run by the NCI (enzalutamide, CRLX101)
Terminated
- Metastatic Castration Resistant Prostate Cancer
- Prostate Neoplasms
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jun 16, 2022
Prostate Cancer, Bone Metastases, Prostate Tumors Trial in United States (LHRH agonist/antagonist, Bicalutamide, Radium-223
Terminated
- Prostate Cancer
- +2 more
- LHRH agonist/antagonist
- +2 more
-
Phoenix, Arizona
- +11 more
Jul 7, 2022
Cancer Of Prostate, Prostate Tumors Trial run by the National Cancer Institute (NCI) (ADT, Prednisone, M7824)
Recruiting
- Cancer Of Prostate
- Prostate Neoplasms
- ADT
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jul 6, 2022
Adenocarcinoma, Prostate Tumors, Prostate Cancer Trial run by the National Institutes of Health Clinical Center (CC) (EM
Enrolling by invitation
- Adenocarcinoma
- +4 more
- EM Tracking
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Apr 7, 2022
Prostate Cancer, Prostate Tumors, Tumors, Prostatic Trial run by the NCI (PROSTVAC-V, PROSTVAC-F, Docetaxel)
Active, not recruiting
- Prostate Cancer
- +2 more
- PROSTVAC-V
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Jan 14, 2022
Prostate Cancer, Prostatic Cancer, Prostatic Tumors Trial in United States (CyberKnife Stereotactic Radiosurgery)
Active, not recruiting
- Prostate Cancer
- +4 more
- CyberKnife Stereotactic Radiosurgery
-
Mobile, Alabama
- +17 more
Mar 3, 2021
Prostate Cancer, Prostatic Cancer, Prostate Tumors Trial in United States (CyberKnife Stereotactic Radiosurgery)
Active, not recruiting
- Prostate Cancer
- +4 more
- CyberKnife Stereotactic Radiosurgery
-
Phoenix, Arizona
- +22 more
Mar 3, 2021
Prostate Tumors Trial in Rome (Pilot evaluation study on use PSMA and Cu-PET/CT)
Completed
- Prostate Neoplasms
- Pilot evaluation study on use PSMA and Cu-PET/CT
-
Rome, ItalyRegina Elena National Cancer Institute
Jan 8, 2021
Cancer of Prostate, Cancer of the Prostate, Tumors, Prostate Trial in Pittsburgh (androgen ablation (AA), DC1 vaccine)
Completed
- Cancer of Prostate
- +6 more
- androgen ablation (AA)
- DC1 vaccine
-
Pittsburgh, PennsylvaniaUniversity of Pittsburgh Cancer institute
Oct 13, 2020
Prostate Tumors, Toxicity Due to Radiotherapy Trial in Tampere (Fractionation, hypofractionated, stereotactic fractionation)
Completed
- Prostate Neoplasms
- Toxicity Due to Radiotherapy
- Fractionation
- +2 more
-
Tampere, FinlandTampere University Hospital
Oct 26, 2020
Prostate Tumors Trial in China (Abiraterone acetate, Placebo, Prednisone)
Completed
- Prostate Neoplasms
- Abiraterone acetate
- +2 more
-
Beijing, China
- +10 more
May 7, 2019
Prostate Cancer, Prostatic Cancer, Prostate Tumors Trial in Seattle (CyberKnife Stereotactic Radiosurgery)
Recruiting
- Prostate Cancer
- +4 more
- CyberKnife Stereotactic Radiosurgery
-
Seattle, WashingtonSwedish Medical Center Radiosurgery Center
Jul 11, 2019
Tumors, Lung Tumors, Colon Tumors Trial in Idaho Falls (Provider determined)
Terminated
- Neoplasms
- +24 more
- Provider determined
-
Idaho Falls, IdahoTeton Cancer Institute
Mar 29, 2019
Prostate Tumors Trial in Brazil (Abiraterone acetate, Prednisone or prednisolone)
No longer available
- Prostate Neoplasms
- Abiraterone acetate
- Prednisone or prednisolone
-
Belo Horizonte, Brazil
- +7 more
Nov 5, 2018
Cancer, Prostate Tumors Trial in Seattle (goserelin with dutasteride, goserelin with bicalutamide and dutasteride, goserelin
Completed
- Cancer
- Prostate Neoplasms
- goserelin with dutasteride
- +2 more
-
Seattle, Washington
- +1 more
Jul 12, 2018
Prostate Tumors, Prostate Cancer Trial in Los Angeles, New York, Madison (Cohort 4, Cohort 3, Cohort 2)
Completed
- Prostate Neoplasms
- Prostate Cancer
- Cohort 4
- +3 more
-
Los Angeles, California
- +2 more
Mar 19, 2018
Prostatic Tumors, Cancer of Prostate, Prostate Cancer Trial in Paris (Laparoscopic Radical Prostatectomy (without a simulator),
Suspended
- Prostatic Neoplasms
- +3 more
- Laparoscopic Radical Prostatectomy (without a simulator)
- Laparoscopic Radical Prostatectomy (with a simulator)
-
Paris, FranceHOPITAL SAINT-LOUIS Service d'urologie
Apr 13, 2017
Prostate Tumors, Genital Tumors, Male, Urogenital Tumors Trial in Worldwide (Abiraterone Acetate, Prednisone\Prednisolone)
Approved for marketing
- Prostate Neoplasms
- +3 more
- Abiraterone Acetate
- Prednisone\Prednisolone
-
Birmingham, Alabama
- +304 more
Mar 23, 2017
Prostate Tumors Trial in Wynnewood ("TrueBeam" stereotactic body radiosurgery)
Unknown status
- Prostate Neoplasms
- "TrueBeam" stereotactic body radiosurgery
-
Wynnewood, PennsylvaniaLankenau Medical Center, Radiation Oncology
Mar 22, 2016